The Effect of Manual Lymphatic Drainage

Investigation of the Effect of Manual Lymphatic Drainag on Venous Ulcer Healing Rate

In venous ulcer, venous insufficiency is accompanied by lymphatic insufficiency. Manual lymphatic drainage (mld) technique cause to increase contraction rate of lymphatic collector and venous flow. It is known that Manual lymphatic drainage accelerates microcirculation, enabling nutrients and oxygen to reach tissues and at the same time removing residual substances from the tissue. We hypothesis that if we inrease to lypmhatic activity with MLD, we could stimulate healing of ulcer. The aim of this study to investigate the effect of manual lymphatic drainage on venous ulcer healing.

Study Overview

Study Type

Interventional

Enrollment (Actual)

10

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Istanbul, Turkey
        • İstanbul Sağlık Bilimleri University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 65 years (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • with venous ulcer unhealing for at least 6 weeks
  • Without enfection
  • vascular surgery is not indicated
  • There is no obstruction to apply MLD and compression to lower extremty

Exclusion Criteria:

  • with diabetic mellutus
  • with enfection
  • with ABI<0,7
  • Patients who have undergone venous vascular surgery
  • Patients undergoing active wound closure treatment

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: NONE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
ACTIVE_COMPARATOR: Manual Lymphatic Drainage Group
All patients were treated 3 times a week for 4 weeks. The treatment program of these patients included manual lymphatic drainage on the leg, skin care, bandaging and exercise.
MLD vith vodder technique was applied to leg
Wound was cleaned with salin and covered by dressing without including active products
breathing and foot pump exercise was prescribed
SHAM_COMPARATOR: Shame Manual Lymphatic Drainage Group
All patients were treated 3 times a week for 4 weeks. The treatment program of these patients included shame manual lymphatic drainage on the leg, skin care, bandaging and exercise. Shame manual lymphatic drainage include light touches instead of real manual lymphatic drainage techniques
Wound was cleaned with salin and covered by dressing without including active products
breathing and foot pump exercise was prescribed
manual lymphatic drainage was applied with light touch instead of real mld techniques

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Evaluation of wound healing
Time Frame: Change from baseline wound healing following the end of treatment (12. treatment session) and 1 month after the end of treatment.
Wound was assesed by analyzing photographes of wound with Tracker software.
Change from baseline wound healing following the end of treatment (12. treatment session) and 1 month after the end of treatment.
Evaluation of range of motion of ankle
Time Frame: Change from baseline range of motion following the end of treatment (12. treatment session) and 1 month after the end of treatment.
range of motion of ankle was measured with goniometer
Change from baseline range of motion following the end of treatment (12. treatment session) and 1 month after the end of treatment.
Evaluation of pain
Time Frame: Change from baseline pain following the end of treatment (12. treatment session) and 1 month after the end of treatment.
Pain was evaluated by Visual Analog Scale between 0 (no pain)-10 (extreme) pain.
Change from baseline pain following the end of treatment (12. treatment session) and 1 month after the end of treatment.
evaluation of edema
Time Frame: Change from baseline edema following the end of treatment (12. treatment session) and 1 month after the end of treatment.
edema was measured by 3D scanner
Change from baseline edema following the end of treatment (12. treatment session) and 1 month after the end of treatment.
evaluation of quality of life
Time Frame: Change from baseline quality of life following scores the end of treatment (12. treatment session) and 1 month after the end of treatment.
quality of life was evaluated by SF- 12
Change from baseline quality of life following scores the end of treatment (12. treatment session) and 1 month after the end of treatment.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Nilüfer Kablan, PhD, University of Health Science

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

September 11, 2018

Primary Completion (ACTUAL)

July 3, 2019

Study Completion (ACTUAL)

May 29, 2020

Study Registration Dates

First Submitted

July 2, 2020

First Submitted That Met QC Criteria

July 2, 2020

First Posted (ACTUAL)

July 8, 2020

Study Record Updates

Last Update Posted (ACTUAL)

July 8, 2020

Last Update Submitted That Met QC Criteria

July 2, 2020

Last Verified

July 1, 2020

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Venous Insufficiency

Clinical Trials on Manual Lymphatic drainage (MLD)

Subscribe